Fresh analysis indicates that people who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end traditional lifestyle regimens.
Published data in a leading health publication shows that while obese individuals can lose about a fifth of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month once they quit.
"Individuals purchasing these drugs should be aware of the potential of quick rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to pre-treatment weight within about a year and a half.
Weighing Treatments
The research, which reviewed dozens of trials involving thousands of participants, compared the results of the injectable medications with conventional dieting.
Scientists note that individuals who shed pounds through diet and exercise typically see a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
The Reason for the Quick Regain
Experts propose the mode of action of the drugs accounts for the amplified rebound.
These medications mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its endogenous GLP-1, and could diminish responsiveness to its actions," said Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' results in hunger is unsuppressed, making overeating much more probable."
A Chronic Issue?
Medical guidelines advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the high risk of weight regain, the treatment is often long-term.
This opinion is reinforced by pharmaceutical companies, who note that the findings "emphasize the persistent nature of excess weight," akin to managing diseases like high blood pressure.
User Testimonies
Users who have come off the jabs report a sudden resurgence of appetite.
"I experienced a switch flipping and I was suddenly ravenous," described an individual.
The struggle is compounded if users have not established lasting lifestyle or habit changes during therapy.
Significant Interest
Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Adoption is more common among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts stress that while the jabs are powerful tools for weight loss, they are not a magic solution and long-term success relies on ongoing lifestyle support.
